Los Angeles Capital Management LLC Neurocrine Biosciences Inc Transaction History
Los Angeles Capital Management LLC
- $29.2 Billion
- Q1 2024
A detailed history of Los Angeles Capital Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 245,381 shares of NBIX stock, worth $33.2 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
245,381
Previous 918,391
73.28%
Holding current value
$33.2 Million
Previous $121 Million
72.03%
% of portfolio
0.12%
Previous 0.45%
Shares
23 transactions
Others Institutions Holding NBIX
# of Institutions
631Shares Held
94.4MCall Options Held
505KPut Options Held
343K-
Black Rock Inc. New York, NY13.8MShares$1.86 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.93MShares$1.34 Billion0.03% of portfolio
-
State Street Corp Boston, MA3.99MShares$540 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.3MShares$311 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.25MShares$305 Million0.49% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...